Trial Profile
A study to investigate effect of Bortezomib with or without Thalidomide on platelet aggregation in patients with relapsed or refractory multiple myeloma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Thalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Nov 2015 New trial record